46
Participants
Start Date
December 31, 2008
Primary Completion Date
March 31, 2013
Study Completion Date
February 28, 2014
Abraxane
"Abraxane is an anti-cancer (antineoplastic or cytotoxic) chemotherapy drug.~Intravesically administered, dose escalation, 6 weekly instillations"
Herbert Irving Pavillion 11th Floor, New York
Collaborators (1)
Celgene Corporation
INDUSTRY
Columbia University
OTHER